BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27098618)

  • 1. Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma.
    Lai S; Wenaas AE; Sandulache VC; Hartman C; Chiao E; Kramer J; Zevallos JP
    Ann Clin Lab Sci; 2016; 46(2):132-9. PubMed ID: 27098618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
    Huber GF; Albinger-Hegyi A; Soltermann A; Roessle M; Graf N; Haerle SK; Holzmann D; Moch H; Hegyi I
    Cancer; 2011 Oct; 117(20):4659-70. PubMed ID: 21448927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
    Lin CM; Lin LW; Chen YW; Ye YL
    Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
    Huang H; Zhang B; Chen W; Zou SM; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma.
    Cooper T; Biron VL; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):250-6. PubMed ID: 25554966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
    Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG; Saba NF
    Head Neck Pathol; 2019 Sep; 13(3):304-312. PubMed ID: 30191505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Sasaki C; Rimm DL; Psyrri A
    Clin Cancer Res; 2004 Sep; 10(17):5684-91. PubMed ID: 15355894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?
    Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L
    Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 not a prognostic marker for hypopharyngeal squamous cell carcinoma.
    Wilson DD; Rahimi AS; Saylor DK; Stelow EB; Jameson MJ; Shonka DC; Reibel JF; Levine PA; Read PW
    Arch Otolaryngol Head Neck Surg; 2012 Jun; 138(6):556-61. PubMed ID: 22710507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
    Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.